sample collection and preservation

Disease to Diagnose

Innovation is to Break The Boundaries

Bifour Biotech Inc. is a medical devices and health care company with headquarter in California, United States. It was founded by a group of senior experts from medical and in-vitro diagnostic field.

LyoGene™ Series

COVID-19 & Influenza A/B Multiplex Assay Kit

It is designed for qualitative and differential diagnosis of SARS-CoV-2, Influenza A and Influenza B nucleic acid in samples.

Applicatable Instrument

Instruments with FAM, HEX/VIC and CY5 channels, such as ABI7500 real time PCR systems, Roche Lightcycler®480/1536/ Nano; Agilent Mx3000P/3005P,Bio-Rad CFX384/CFX96

Technical Parameters

Product features Parameter
Specimen Type nasopharyngeal, pharyngeal swab, sputum
Technical Platform PCR-fluorescent Probe
Detection Types 2019nCOV: N Gene Influenza A/ Influenza B virus: NP Gene
Internal Control RNase P
Quality Control UNG enzyme + dUTP anti-contamination system
Amplification Time 90 min
Sensitivity 100 copies/mL

Order Information

Name Cat.No. Specifications Sample Type
Influenza A/B/NV
Nucleic Acid Detection Kit
GSP3105-48 48 test/Kit nasopharyngeal/pharyngeal swab, sputum
GSP3105-96 96 test/Kit

Interest in our Products?

Don’t hesitate to contact us for more detailed information

Discover How We Are Getting Ahead

© Copyright 2022 Bifour | All Rights Reserved